elucidated that treatment of RA patients with 99Tc-methylene diphosphonate (99Tc-MDP) significantly increases γδ T cells and Tregs, alongside decreased TNF-α and IL-6 levels and elevated TGF-β expression, indicating a potential role in promoting immune tolerance under specific conditions (84). Here, TNF is linked to rheumatoid arthritis.